Handbook of Clinical medicine
KEYWORDS: patient, disease, patients, history, pain, heart, symptoms, ask, time, treatment, risk, examination, aortic, iinnddbb, pulse

precipitate KS. Lung KS may present in HI V +ve men and women as dyspnoea and haemoptysis. Bowel KS may cause nausea, abdominal pain. Rare sites: CNS, larynx, eye, glands, heart, breast, wounds, or biopsy sites. : Biopsy. : Optimize HAART, local radiotherapy, surgical excision, intralesional therapy (vincristine, bleomycin), topical retinoids, interferon alfa, interleukin-12. Current research includes thalidomide, VEGF monoclonal antibodies, and sirolimus. Moricz Kaposi, 1837–1902 (Hungarian dermatologist) __OOHHCCMM__1100ee..iinnddbb 770022 0022//0055//22001177 1199::0088 semordnys suomynopE Guillain–Barré polyneuritis 703 Table 15.2 Diagnostic criteria Features required for Features supporting diagnosis Progressive weakness of >1 limb • Progression over days, up to 4wks Arefl exia • Near symmetry of sytoms Features making diagnosis doubtful • Sensory symptoms/signs only mild • Sensory level • CN involvement (eg bilateral facial weakness) • Marked, persistent asymmetry of • Recovery starts ~2wks after the period of weakness progression has fi nished • Severe bowel and bladder dysfunction • Autonomic dysfunction • CSF WCC >50 • Absence of fever at onset • CSF protein  with CSF WCC <10≈106/L • Typical electrophysiological tests Variants of Guillain–Barré syndrome include: Chronic infl ammatory demyelinating polyradiculopathy (CIDP): Characteri zed by a slower onset and recovery. Miller Fisher syndrome: Comprises of ophthalmoplegia, ataxia,
